Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/22308
Title: Obstructive sleep apnea, cognition and Alzheimer's disease: A systematic review integrating three decades of multidisciplinary research.
Authors: Bubu, Omonigho M;Andrade, Andreia G;Umasabor-Bubu, Ogie Q;Hogan, Megan M;Turner, Arlener D;de Leon, Mony J;Ogedegbe, Gbenga;Ayappa, Indu;Jean-Louis G, Girardin;Jackson, Melinda L;Varga, Andrew W;Osorio, Ricardo S
Affiliation: School of Health & Biomedical Sciences, RMIT University, Bundoora, Victoria, Australia
Department of Radiology, Weill Cornell Medicine, New York, NY 10065, USA
Department of Population Health, New York University School of Medicine, Center for Healthful Behavior Change, New York, USA
Center for Brain Health, Department of Psychiatry, NYU Langone Medical Center, New York, NY, USA
Department of Epidemiology and Biostatistics, College of Public Health, University of South Florida, Tampa, FL, USA
Department of Applied Health Sciences, Wheaton College, Wheaton, IL, USA
Department of Human Services and Psychology, National Louis University, Chicago, IL, USA
Institute for Breathing and Sleep, Austin Health, Heidelberg, Victoria, Australia
State University New York (SUNY) Downstate, USA
Department of Applied Health Sciences, Wheaton College, Wheaton, IL, USA
Division of Pulmonary, Critical Care and Sleep Medicine at the Icahn School of Medicine at Mount Sinai, New York, NY, USA
Center for Brain Health, Department of Psychiatry, NYU Langone Medical Center, New York, NY, USA
Issue Date: Apr-2020
EDate: 2019-12-12
Citation: Sleep medicine reviews 2020; 50: 101250
Abstract: Increasing evidence links cognitive-decline and Alzheimer's disease (AD) to various sleep disorders, including obstructive sleep apnea (OSA). With increasing age, there are substantial differences in OSA's prevalence, associated comorbidities and phenotypic presentation. An important question for sleep and AD researchers is whether OSA's heterogeneity results in varying cognitive-outcomes in older-adults compared to middle-aged adults. In this review, we systematically integrated research examining OSA and cognition, mild cognitive-impairment (MCI) and AD/AD biomarkers; including the effects of continuous positive airway pressure (CPAP) treatment, particularly focusing on characterizing the heterogeneity of OSA and its cognitive-outcomes. Broadly, in middle-aged adults, OSA is often associated with mild impairment in attention, memory and executive function. In older-adults, OSA is not associated with any particular pattern of cognitive-impairment at cross-section; however, OSA is associated with the development of MCI or AD with symptomatic patients who have a higher likelihood of associated disturbed sleep/cognitive-impairment driving these findings. CPAP treatment may be effective in improving cognition in OSA patients with AD. Recent trends demonstrate links between OSA and AD-biomarkers of neurodegeneration across all age-groups. These distinct patterns provide the foundation for envisioning better characterization of OSA and the need for more sensitive/novel sleep-dependent cognitive assessments to assess OSA-related cognitive-impairment.
URI: http://ahro.austin.org.au/austinjspui/handle/1/22308
DOI: 10.1016/j.smrv.2019.101250
PubMed URL: 31881487
Type: Journal Article
Review
Subjects: Alzheimer's disease
Amyloid
Biomarkers
Cognition
Middle aged
Mild cognitive impairment
Obstructive sleep apnea
Older adults
Phosphorylated tau
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.